Corpus Intelligence IC Memo — CENTRAL STATE HOSPITAL 2026-04-26 15:55 UTC
IC Memo — CENTRAL STATE HOSPITAL
Investment Committee Memorandum | KY | 70 beds | Grade D | EBITDA uplift $361K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CENTRAL STATE HOSPITAL

CCN 184015 | JEFFERSON, KY | 70 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

CENTRAL STATE HOSPITAL is a 70-bed under-performing / distressed in JEFFERSON, KY with $4.7M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 7.2% Medicare, 0.3% Medicaid, and 92.4% commercial.

Thesis: Turnaround. Our ML models identify $361K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -428.2% (+762bps).

Net Revenue HCRIS$4.7M
Current EBITDA COMPUTED$-20.6M
Operating Margin COMPUTED-100.0%
Occupancy HCRIS74.7%
Revenue / Bed COMPUTED$68K
Net-to-Gross HCRIS22.2%
Distress Probability ML41.4%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
50
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -100.0% places it below the state median. Among 50 size-comparable peers (35-140 beds), the median margin is 0.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (35-140), prioritizing same-state peers. 50 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CENTRAL STATE HOSPITAL (Target)KY70$4.7M-100.0%
BAPTIST HEALTH LAGRANGEKY42$236.9M2.7%
ST. ELIZABETH FLORENCEKY134$212.6M8.8%
SAINT JOSEPH EASTKY138$209.5M2.6%
ST. CLAIRE MEDICAL CENTERKY100$204.5M-8.5%
HAZARD ARHKY109$200.8M-32.3%
T.J. SAMSON COMMUNITY HOSPITALKY112$189.4M-10.5%
SAINT JOSEPH LONDONKY118$173.7M-8.1%
JENNIE STUART MEDICAL CENTERKY122$165.3M-6.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $361K (762bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$99K+210bp18mo
Denial Rate Reduction12.0%6.5%$99K+210bp12mo
Cost to Collect4.5%2.5%$95K+200bp12mo
A/R Days Reduction5200.0%3800.0%$58K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+20bp6mo

5. EBITDA Bridge

Net Collection Rate
$99K
Denial Rate Reduction
$99K
Cost to Collect
$95K
A/R Days Reduction
$58K
Clean Claim Rate
$10K
Total EBITDA Uplift$361K
Current EBITDA$-20.6M
+ RCM Uplift+$361K
Pro Forma EBITDA$-20.3M
Current Margin-100.0%
Pro Forma Margin-428.2%
WC Released (1x)$182K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-31.8M$-132.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-31.8M$-156.2M0.00x-100.0%
Bull Case9.0x11.0x$-28.6M$-165.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-28.6M$-188.7M0.00x-100.0%
Bear Case11.0x10.0x$-34.9M$-124.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-34.9M$-147.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 50 hospitals with 35-140 beds
  • Same-state prioritization (n=51)
  • Comp margins: P25=-9.3% / P50=0.1% / P75=10.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.